{"id":102535,"date":"2024-02-05T18:40:10","date_gmt":"2024-02-05T13:10:10","guid":{"rendered":"http:\/\/finservwealth.com\/suven-pharma-q3-results-net-profit-down-57-yoy-to-rs-47-crore\/"},"modified":"2024-02-05T18:40:10","modified_gmt":"2024-02-05T13:10:10","slug":"suven-pharma-q3-results-net-profit-down-57-yoy-to-rs-47-crore","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/suven-pharma-q3-results-net-profit-down-57-yoy-to-rs-47-crore\/","title":{"rendered":"Suven Pharma Q3 results: Net profit down 57% YoY to Rs 47 crore"},"content":{"rendered":"<p> The pharma company expects that the next few quarters to continue to be soft due to the impact of global destocking in specialty chemicals and FY23 base effect<\/p><div id=\"finse-3300382431\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/suven-pharma-q3-results-net-profit-down-57-yoy-to-rs-47-crore_17430131.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The pharma company expects that the next few quarters to continue to be soft due to the impact of global destocking in specialty chemicals and FY23 base effect The pharma company expects that the next few quarters to continue to be soft due to the impact of global destocking in specialty chemicals and FY23 base effect\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/suven-pharma-q3-results-net-profit-down-57-yoy-to-rs-47-crore_17430131.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> The pharma company expects that the next few quarters to continue to be soft due to the impact of global destocking in specialty chemicals and FY23 base effect<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/suven-pharma-q3-results-net-profit-down-57-yoy-to-rs-47-crore_17430131.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The pharma company expects that the next few quarters to continue to be soft due to the impact of global destocking in specialty chemicals and FY23 base effect The pharma company expects that the next few quarters to continue to be soft due to the impact of global destocking in specialty chemicals and FY23 base effect\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/suven-pharma-q3-results-net-profit-down-57-yoy-to-rs-47-crore_17430131.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> The pharma company expects that the next few quarters to continue to be soft due to the impact of global destocking in specialty chemicals and FY23 base effect<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-102535","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2023\/200x200\/P\/Pharma-production_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/102535","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=102535"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/102535\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=102535"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=102535"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=102535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}